Search Results
Safety of Monoclonal Antibodies in Myeloma
Safety Profile of Anti-CD38 Monoclonal Antibodies in MM
Monoclonal antibodies for multiple myeloma
Comparison of the safety & efficacy of CAR-T therapy vs bispecifics in R/R multiple myeloma
REGN5458, a BCMAxCD3 Bispecific Monoclonal Antibody, in a Phase 1/2 1st-in-Human Study in RRMM Pts
Safety & efficacy of bispecific antibodies in multiple myeloma: teclistamab & elranatamb
Efficacy and safety of elranatamab BCMA-CD3 bispecific antibody, in patients with RRMM
Safety and Efficacy: Elotuzumab
Reaching the Next Level of Myeloma Patient Care: Antibody Therapy and Novel Mechanisms of Action
Efficacy and Safety of Elotuzumab and Daratumumab
Monoclonal antibodies and multiple myeloma
Updated Efficacy/Safety Results of MajesTEC-1 (Teclistamab) at ASCO 2022
